A fatal case of coxsackievirus B4 meningoencephalitis

Archives of Neurology

Volumn 60, Issue 1, 2003, Pages 107-112

  Cree, Bruce C ^a   Bernardini, Gary L ^a   Hays, Arthur P ^a   Lowe, Gina ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAPHYLACTOID PURPURA; ARTICLE; ASEPTIC MENINGITIS; CASE REPORT; CENTRAL NERVOUS SYSTEM INFECTION; CONTRAST ENHANCEMENT; COXSACKIE VIRUS B4; EXTRAPYRAMIDAL SYMPTOM; FATALITY; FEMALE; HUMAN; MENINGOENCEPHALITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SAMPLING;

EID: 0037227108     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.1.107     Document Type: Article

References (43)

1. Tyler KL, Martin JB. Infectious Diseases of the Nervous System. Philadelphia, Pa: FA Davis Co; 1993.
2. Cherry JD. Enteroviruses: coxsackieviruses, echoviruses, and polioviruses. In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. 4th ed. Philadelphia, Pa: WB Saunders Co; 1998:1787-1838.
3. Artenstein MS, Cadigan FC, Buescher EL. Clinical and epidemiological features of coxsackie group B virus infection. Ann Intern Med. 1965;4:597-603.
4. Moore M, Kaplan MK, McPhee J, Bregman DJ, Klein SW. Epidemiologic, clinical, and laboratory features of Coxsackie B1-B5 infections in the United States, 1970-79. Public Health Rep. 1984;99:515-522.
5. Strikas RA, Anderson LJ, Parker RA. Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970-1983. J Infect Dis. 1986;153:346-351.
6. Pallansch MA. Coxsackie B epidemiology and public health concerns. Curr Top Microbiol Immunol. 1997;223:13-30.
7. Rotbart HA, O'Connell JF, McKinlay MA. Treatment of human enterovirus infections. Antiviral Res. 1998;38:1-14.
8. Rogers JM, Diana GD, McKinlay MA. Pleconaril: a broad spectrum antipicornaviral agent. Adv Exp Med Biol. 1999;458:69-76.
9. Bickerstaff ER, Cloake PCP. Mesencephalitis and rhombencephalitis. BMJ. 1951;14:77-81.
10. Nielson JM. Complication of encephalitis of the von Economo type. Bull Los Angeles Neurol Soc. 1953;18:84-90.
11. Espir MLB, Spalding JMK. Three recent cases of encephalitis lethargica. BMJ. 1956;19:1141-1144.
12. Hunter R, Jones M. Acute lethargica-type encephalitis. Lancet 1966;5:1023-1024.
13. Clough CG, Plaitakis A, Yahr MD. Oculogyric crises and parkinsonism: a case of recent onset. Arch Neurol. 1983;40:36-37.
14. Howard RS, Lees AJ. Encephalitis lethargica: a report of four recent cases. Brain. 1987;110:19-33.
15. Picard F, de Saint-Martin A, Salmon E, Hirsch E, Marescaux C. Postencephalitic stereotyped involuntary movements responsive to L-dopa. Mov Disord. 1996;11:567-570.
16. Blunt SB, Lane RJM, Turjanski N, Perkin GD. Clinical features and management of two cases of encephalitis lethargica. Mov Disord. 1997;12:354-359.
17. Kun LN, Yian SY, Haur LS, Tjia H. Bilateral substantia nigra changes on MRI in a patient with encephalitis lethargica. Neurology. 1999;53:1860-1862.
18. Rail D, Schotz C, Swash M. Post-encephalitic parkinsonism: current experiences. J Neurol Neurosurg Psychiatry. 1981;44:670-676.
19. von Economo C. Encephalitis Lethargica: Its Sequelae and Treatment. Newman KD, trans. London, England: Oxford University Press; 1931.
20. Duvoisin RC, Yahr MD. Encephalitis and parkinsonism. Arch Neurol. 1965;12:227-239.
21. Williams A, Houff S, Lees A, Calne D. Oligoclonal banding in the cerebrospinal fluid of patients with postencephalitic parkinsonism. J Neurol Neurosurg Psychiatry. 1979;42:790-792.
22. Hallervorden J. Anatomische Untersuchungen zur Pathogenes des postencephalitischen Parkinsonismus. Dtsch Z Nervenheilkd. 1935;136:68-77.
23. Bojlnov S. Encephalitis with acute parkinsonian syndrome and bilateral inflammatory necrosis of the substantia nigra. J Neurol Sci. 1971;12:383-415.
24. McApline D. The pathology of the parkinsonian syndrome following encephalitis lethargica, with a note on the occurrence of calcification in this disease. Brain. 1923;46:255-281.
25. Elizan TS, Casals J. Astrogliosis in von Economo's and postencephalitic Parkinson's diseases supports probable viral etiology. J Neurol Sci. 1991;105:131-134.
26. Casals J, Elizan TS, Yahr MD. Postencephalitic parkinsonism: a review. J Neural Transm. 1998;105:645-676.
27. Walters JH. Postencephalitic Parkinson syndrome after meningoencephalitis due to coxsackie virus group B, type 2. N Engl J Med. 1960;263:744-747.
28. Poser CM, Huntley C, Poland JD. Para-encephalitic parkinsonism: report of an acute case due to coxsackie type B 2 and re-examination of the etiologic concepts of postencephalitic parkinsonism. Acta Neurol Scand. 1969;45:199-215.
29. Ishii T, Matsushita M, Hamada S. Characteristic residual neuropathological features of Japanese B encephalitis. Acta Neuropathol. 1977;38:181-186.
30. Shoji H, Watanabe M, Itoh S, Kuwahara H, Hattori F. Japanese encephalitis and parkinsonism. J Neurol. 1993;240:59-60.
31. Mulder DW, Parrott M, Thaler M. Sequelae of western equine encephalitis. Neurology. 1951;1:318-327.
32. Meyer B. Encephalitis after measles with severe parkinsonian rigidity: recovery. BMJ. 1943;24:508.
33. Al-Mateen M, Gibbs M, Dietrich R, Mitchell WG, Menkes JH. Encephalitis lethargica-like illness in a girl with mycoplasma infection. Neurology. 1988;38:1155-1158.
34. Rotbart HA, Brennan PJ, Fife KH, et al. Enterovirus meningitis in adults. Clin Infect Dis. 1998;27:896-898.
35. Javett SN, Heymann S, Mundel B, et al. Myocarditis in the newborn infant: a study of an outbreak associated with coxsackie B virus infection in a maternity home in Johannesburg. J Pediatr. 1956;48:1-22.
36. Rapmund G, Gauld JR, Rogers NG, Holmes GE. Neonatal myocarditis and meningoencephalitis due to coxsackie virus group B, type 4. N Engl J Med. 1959;260:819-821.
37. Kaplan MH, Klein SW, McPhee J, Harper RG. Group B coxsackie virus infections in infants younger than three months of age: a serious childhood illness. Rev Infect Dis. 1983;5:1019-1032.
38. Wilfert CM, Buckley RH, Mohanakumar T, et al. Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. N Engl J Med. 1977;296:1485-1489.
39. McKinney RE Jr, Katz SI, Wilfert CM. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis. 1987;9:334-356.
40. Webster AD, Rotbart HA, Warner T, Rudge P, Hyman N. Diagnosis of enterovirus brain disease in hypogammaglobulinemic patients by polymerase chain reaction. Clin Infect Dis. 1993;17:657-661.
41. Moosy J, Geer JC. Encephalomyelitis, myocarditis and adrenal cortical necrosis in coxsackie B3 virus infection. Arch Pathol Lab Med. 1960;70:614-622.
42. Estes ML, Rorke LB. Liquefaction necrosis in coxsackie B encephalitis. Arch Pathol Lab Med. 1986;110:1090-1092.
43. Schmugge M, Lauener R, Bossart W, et al. Chronic enteroviral meningoencephalitis in X-linked agammaglobulinaemia: favorable response to antienteroviral treatment. Eur J Pediatr. 1999;158:1010-1011.